Citation: U. Krugel et al., IN-VIVO EFFECTS OF 2-METHYLTHIO ATP AFTER APPLICATION INTO THE VENTRAL TEGMENTAL AREA - A MICRODIALYSIS, BEHAVIORAL AND IMMUNOHISTOCHEMICALSTUDY, European journal of neuroscience, 10, 1998, pp. 11312-11312
Citation: H. Kittner et al., P2 PURINOCEPTOR-MEDIATED DOPAMINE RELEASE IN THE NUCLEUS-ACCUMBENS AND ITS REGULATION, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 62-62
Citation: U. Krugel et al., P2 RECEPTOR-MEDIATED REGULATION OF THE ACTIVITY OF DOPAMINERGIC-NEURONS IN THE VENTRAL TEGMENTAL AREA, Naunyn-Schmiedeberg's archives of pharmacology, 358(4), 1998, pp. 71-71
Citation: H. Franke et al., IMMUNOHISTOCHEMICAL STUDIES ON PURINOCEPTOR-MEDIATED PROLIFERATIVE EFFECTS ON ASTROCYTES IN-VIVO, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 129-129
Citation: H. Kittner et al., 2-METHYLTHIO ATP (2-MESATP) ENHANCES DOPAMINERGIC MECHANISMS IN THE MESOLIMBIC MESOCORTICAL SYSTEM OF THE RAT - AN IN-VIVO STUDY, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 207-207
Citation: H. Kittner et al., INFLUENCE OF 2-METHYLTHIO ATP (2-MESATP) ON THE MESOLIMBIC MESOCORTICAL DOPAMINERGIC SYSTEM OF THE RAT - MICRODIALYSIS, ELECTROENCEPHALOGRAPHY AND BEHAVIOR, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 113-113